HABIT-ILE therapy for children with acquired brain injury
Official title: Implementation of a HABIT-ILE Intervention at William Lennox Neurological : a Randomized Controlled Trial
Run by Université Catholique de Louvain · NCT05900778 · Data updated 2026-11-12
This study is testing a new therapy called HABIT-ILE to see if it can help children aged 5 to 18 with brain injuries improve their daily activities and skills better than regular treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Years to 18 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Université Catholique de Louvain Academic / other |
| Locations | 3 sites (Ottignies-Louvain-la-Neuve, Brabant-Wallon and 2 other locations) |
| Status | Recruiting |
| Started | June 10, 2023 |
| Main results expected | December 20, 2024 |
| Study ends | June 10, 2028 |
| Registry record updated | June 18, 2023 |
| Trial ID | NCT05900778 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 5 to 18 years with acquired brain injuries who are stable and can participate in the intervention.
✕Probably not a fit
Patients with unstable seizures or severe visual or cognitive impairments that interfere with the intervention or testing are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of the Hand-arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) in a hospital setting for children aged 5 to 18 with acquired brain injuries. It employs a randomized controlled trial design to compare the outcomes of HABIT-ILE therapy against conventional therapies. The study aims to assess improvements in functional activities of daily living, motor skills, and cognitive abilities through clinical evaluations conducted before and after the treatment. The goal is to provide objective evidence of the therapy's effectiveness in enhancing the quality of life for affected children.
Why it matters
Potential benefit: If successful, this therapy could significantly improve motor and cognitive functions in children with acquired brain injuries, enhancing their daily living activities.
How similar studies have gone: Other studies have shown promising results with intensive therapy approaches for similar conditions, suggesting potential success for this novel application of HABIT-ILE.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * children with acquired brain injury of school * age 5 to 18 years inclusive Exclusion Criteria: * Unstable seizure * programmed botulinum toxin or orthopedic surgery in the 6 months previous to the intervention, during intervention period or 3months after the intervention time * Severe visual or cognitive impairments likely to interfere with intervention or testing session completion
Where it's running
-
Centre Hospitalier Neurologique William Lennox
Ottignies-Louvain-la-Neuve, Brabant-Wallon, Belgium Recruiting -
Institute of Neurosciences, UCLouvain
Brussels, Belgium Recruiting -
Spontaneous contact via doctors or other partners
Brussels, Belgium Recruiting
Study contacts
- Principal investigator: Yannick Bleyenheuft, Professor — Insititue of Neurosciences, UCLouvain
- Study coordinator: Yannick Bleyenheuft, Professor
- Email: yannick.bleyenheuft@uclouvain.be
- Phone: +32 2 764 93 49
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Caregivers and patients with severe brain injury: using the SAFE scale to monitor behavior together
A caregiver-friendly tool called the SAFE scale is tested to see if involving family members in daily observations helps care teams track DoC patients more consistently.
-
Web-based therapy for cognitive and speech rehabilitation in hospital
This project will try delivering cognitive and speech therapy through a web-based platform called Cognishine for adults in hospital after stroke or other acquired brain injury.
-
Sensor robot-assisted therapy for kids with brain injury
This trial tests Inrobics Rehab, a robot-assisted home and clinic therapy, to see if it helps children aged 7-16 with acquired brain injury improve motor, thinking, and social skills while being easy to use.
-
Acoustic and breathing tests for dysarthria after acquired brain injury
This study will see if combining voice recordings, breathing tests, and a clinical speech check can help identify the type and severity of dysarthria in adults after an acquired brain injury.
-
Driving simulator training for adults with acquired brain injury
This project will test whether eight sessions of driving-simulator training help adults with acquired brain injury become more comfortable, confident, and ready for on-road driving compared with traditional occupational therapy.
-
Comparing Ceriter Stride-One smart insoles with GRAIL gait measurements
We will test whether Ceriter Stride-One pressure-sensitive insoles give the same gait measurements as the GRAIL system for people with stroke, incomplete spinal cord injury, or acquired/traumatic brain injury who can walk independently for at least six minutes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.